| Health data cooperatives–citizen empowerment E Hafen, D Kossmann, A Brand Methods of information in medicine 53 (02), 82-86, 2014 | 153 | 2014 |
| The impact of genetics and genomics on public health A Brand, H Brand, T Schulte in den Bäumen European Journal of Human Genetics 16 (1), 5-13, 2008 | 152 | 2008 |
| The future of technologies for personalised medicine A Harvey, A Brand, ST Holgate, LV Kristiansen, H Lehrach, A Palotie, ... New biotechnology 29 (6), 625-633, 2012 | 148 | 2012 |
| An index of barriers for the implementation of personalised medicine and pharmacogenomics in Europe D Horgan, M Jansen, L Leyens, JA Lal, R Sudbrak, E Hackenitz, ... Public health genomics 17 (5-6), 287-298, 2014 | 110 | 2014 |
| Neonatal and postneonatal mortality in Germany since unification E Nolte, A Brand, I Koupilová, M McKee Journal of Epidemiology & Community Health 54 (2), 84-90, 2000 | 90 | 2000 |
| Genome-based health literacy: a new challenge for public health genomics EV Syurina, I Brankovic, N Probst-Hensch, A Brand Public Health Genomics 14 (4-5), 201-210, 2011 | 79 | 2011 |
| Scanning the horizon: a systematic literature review of methodologies P Hines, LH Yu, RH Guy, A Brand, M Papaluca-Amati BMJ open 9 (5), e026764, 2019 | 69 | 2019 |
| Success stories in genomic medicine from resource-limited countries K Mitropoulos, H Al Jaibeji, DA Forero, P Laissue, A Wonkam, ... Human genomics 9, 1-7, 2015 | 67 | 2015 |
| Improving data and knowledge management to better integrate health care and research M Cases, LI Furlong, J Albanell, RB Altman, R Bellazzi, S Boyer, A Brand, ... Journal of internal medicine 274 (4), 321, 2013 | 61 | 2013 |
| Use of big data for drug development and for public and personal health and care L Leyens, M Reumann, N Malats, A Brand Genetic epidemiology 41 (1), 51-60, 2017 | 57 | 2017 |
| Biobanking for epidemiological research and public health AM Brand, NM Probst-Hensch Pathobiology 74 (4), 227-238, 2007 | 55 | 2007 |
| Sample, data use and protection in biobanking in Europe: legal issues E Zika, T Schulte In den Bäumen, J Kaye, A Brand, D Ibarreta Pharmacogenomics 9 (6), 773-781, 2008 | 47 | 2008 |
| Public health and genetics—a dangerous combination? A Brand The European Journal of Public Health 15 (2), 114-116, 2005 | 45 | 2005 |
| Prevention and treatment of vitamin D deficiency in Dutch psychogeriatric nursing home residents by weekly half-body UVB exposure after showering: a pilot study VGM Chel, ME Ooms, S Pavel, F De Gruijl, A Brand, P Lips Age and ageing 40 (2), 211-214, 2011 | 44 | 2011 |
| Cross-border health activities in the Euregios: Good practice for better health H Brand, A Hollederer, U Wolf, A Brand Health policy 86 (2-3), 245-254, 2008 | 44 | 2008 |
| Test pricing and reimbursement in genomic medicine: towards a general strategy A Vozikis, DN Cooper, C Mitropoulou, ME Kambouris, A Brand, V Dolzan, ... Public Health Genomics 19 (6), 352-363, 2017 | 43 | 2017 |
| Potentials and challenges of the health data cooperative model I Van Roessel, M Reumann, A Brand Public health genomics 20 (6), 321-331, 2018 | 39 | 2018 |
| Advances in development and application of human organoids A Shankaran, K Prasad, S Chaudhari, A Brand, K Satyamoorthy 3 Biotech 11 (6), 257, 2021 | 38 | 2021 |
| Chlamydia trachomatis Infections and Subfertility: Opportunities to Translate Host Pathogen Genomic Data into Public Health JA Lal, J Malogajski, SP Verweij, P De Boer, E Ambrosino, A Brand, ... Public Health Genomics 16 (1-2), 50-61, 2013 | 38 | 2013 |
| Personalized medicine: what’s in it for rare diseases? S Schee genannt Halfmann, L Mählmann, L Leyens, M Reumann, ... Rare diseases epidemiology: update and overview, 387-404, 2017 | 37 | 2017 |